[Achievements in the diagnosis and treatment of immune myocarditis].
Paleev
N R
NR
Paleev
F N
FN
D000208:Acute Disease; D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use; D001323:Autoantibodies; D001324:Autoantigens; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology; D002317:Cardiovascular Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002908:Chronic Disease; D004247:DNA / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D008763:Methylhydrazines / Q000008:administration & dosage / Q000627:therapeutic use; D009205:Myocarditis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000276:immunology; D009206:Myocardium / Q000276:immunology; D012008:Recurrence; D013601:T-Lymphocytes / Q000276:immunology; D014777:Virus Diseases / Q000150:complications
D000276:Adjuvants, Immunologic; D001323:Autoantibodies; D001324:Autoantigens; D002317:Cardiovascular Agents; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents; D008763:Methylhydrazines; C050147:3-(2,2,2-trimethylhydrazine)propionate; D004247:DNA